Back to Peptides
musclefat losslongevity

Tesamorelin + Ipamorelin Blend

Also known as Tesamorelin + Ipamorelin, Tesamorelin / Ipamorelin blend

Blended GHRH analogue and ghrelin-mimetic growth hormone secretagogue for body composition and recovery.

Medical status: Not approved as a medicine; sold as a research blend.

Also commonly used for (off-label)

  • Visceral fat loss and body recomposition
  • Growth hormone support from a single vial
  • Recovery and overnight sleep quality

Off-label and research uses are what people report, not approved indications. Talk to a clinician before using any of them.

How it's taken (route)

Documented dose
1–2 mg
Typical frequency
1 time daily, 5 days on / 2 days off
Cycle
12 weeks on, 4 off
Half-life
~26–38 minutes for Tesamorelin; ~2 hours for Ipamorelin
Common vial sizes
10 mg, 20 mg
Regulatory status
Not approved for human use in most jurisdictions.

Dose on a U-100 syringe (1–2 mg)

VialBAC waterDraw
10 mg2 mL20–40 units
10 mg2.5 mL25–50 units
20 mg3 mL15–30 units
20 mg5 mL25–50 units

On a U-100 syringe, 100 units = 1 mL, and the syringe holds 100 units total. Most people keep a single subcutaneous injection under about 50 units — bigger volumes are usually mixed stronger (less water) or split into two shots. Only mixes that fit in one syringe are shown. Always double-check with the reconstitution calculator.

What it does

A pre-mixed combination of Tesamorelin and Ipamorelin that targets visceral fat loss and growth hormone release together. Tesamorelin is a GHRH analogue that specifically raises growth hormone in the abdominal region, while Ipamorelin mimics ghrelin to trigger a clean GH pulse from the pituitary. The combination is used for body recomposition, visceral fat reduction, and recovery support. What people look into it for: • Reducing visceral belly fat • Supporting lean muscle and recovery • Improving sleep quality and overnight recovery • A simplified protocol from a single vial

Mechanism

Tesamorelin binds GHRH receptors to increase endogenous growth hormone secretion, with a particular effect on visceral adipose tissue. Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) to release an additional GH pulse without meaningfully raising cortisol, prolactin or hunger. The two peptides act through complementary pathways in a single injection.

Storage — lyophilisedwhat's this?

Refrigerate 2-8°C, protect from light.

Storage — reconstitutedwhat's this?

Refrigerate 2-8°C, use within ~28 days.

Reconstitution noteswhat's this?

Common mix: 10 mg total peptide blend + 2 ml bacteriostatic water = 50 mcg per unit. A 1 mg Tesamorelin dose would draw 20 units; the same volume also delivers the blended Ipamorelin component.

Commonly reported side effects

  • Injection-site redness
  • Water retention
  • Head rush
  • Hunger
  • Drowsiness
  • Tingling hands

Contraindications noted

  • Active malignancy
  • Pregnancy or breastfeeding
  • Uncontrolled diabetes

Research notes

Tesamorelin is best known for its research in HIV-associated lipodystrophy; the blend format is commonly used for convenience in body-recomposition protocols.

Vendors carrying Tesamorelin + Ipamorelin Blend

These research suppliers list this compound. Prices, vial sizes and testing vary — always check the current lot certificate before you buy.

Peptide Streak does not sell peptides and is not affiliated with these vendors. Some list metabolic compounds under coded product names.

Track this properly

Work out syringe units with the calculator, or set up a full schedule in about a minute.

Reference information only, not medical advice. See our medical disclaimer.